South Dakota Trust Company Llc - Net Worth and Insider Trading

South Dakota Trust Company Llc Net Worth

The estimated net worth of South Dakota Trust Company Llc is at least $1.2 Billion dollars as of 2024-11-07. South Dakota Trust Company Llc is the 2301 Trustee of Alphamab Oncology and owns about 314,000,000 shares of Alphamab Oncology (HKSE:09966) stock worth over $1.2 Billion. Details can be seen in South Dakota Trust Company Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that South Dakota Trust Company Llc has not made any transactions after 2023-04-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of South Dakota Trust Company Llc

To

South Dakota Trust Company Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, South Dakota Trust Company Llc owns 1 companies in total, including Alphamab Oncology (HKSE:09966) .

Click here to see the complete history of South Dakota Trust Company Llc’s form 4 insider trades.

Insider Ownership Summary of South Dakota Trust Company Llc

Ticker Comapny Transaction Date Type of Owner
HKSE:09966 Alphamab Oncology 2023-04-21 2301 Trustee

South Dakota Trust Company Llc Latest Holdings Summary

South Dakota Trust Company Llc currently owns a total of 1 stock. South Dakota Trust Company Llc owns 314,000,000 shares of Alphamab Oncology (HKSE:09966) as of April 21, 2023, with a value of $1.2 Billion.

Latest Holdings of South Dakota Trust Company Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:09966 Alphamab Oncology 2023-04-21 314,000,000 3.87 1,215,180,000

Holding Weightings of South Dakota Trust Company Llc


South Dakota Trust Company Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, South Dakota Trust Company Llc has made a total of 4 transactions in Alphamab Oncology (HKSE:09966) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Alphamab Oncology is the sale of 0 shares on April 21, 2023, which brought South Dakota Trust Company Llc around $0.

Insider Trading History of South Dakota Trust Company Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

South Dakota Trust Company Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

South Dakota Trust Company Llc Ownership Network

Ownership Network List of South Dakota Trust Company Llc

No Data

Ownership Network Relation of South Dakota Trust Company Llc

Insider Network Chart

South Dakota Trust Company Llc Owned Company Details

What does Alphamab Oncology do?

Who are the key executives at Alphamab Oncology?

South Dakota Trust Company Llc is the 2301 Trustee of Alphamab Oncology. Other key executives at Alphamab Oncology include 2305 Beneficiary of a trust Xu Ting , 2307 Founder of a discretionary trust who can infl LIU YANG , and 2101 Beneficial owner Rubymab Ltd. .

Alphamab Oncology (HKSE:09966) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alphamab Oncology (HKSE:09966) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alphamab Oncology (HKSE:09966) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alphamab Oncology (HKSE:09966)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alphamab Oncology Insider Transactions

No Available Data

South Dakota Trust Company Llc Mailing Address

Above is the net worth, insider trading, and ownership report for South Dakota Trust Company Llc. Currently GuruFocus does not have mailing address information for South Dakota Trust Company Llc.